Skip to main content

Table 4 Characteristics of patients with AATD-related mutations

From: Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia

Variable

n = 23

Age, median (p25-p75)

73 (69.5–77.4)

Male, n (%)

14 (60.9)

Lung function

FVC post-BD in litres, median (p25-p75)

2.47 (1.86–3.45)

FVC post-BD as percentage, median (p25-p75)

91 (64–105)

FEV1 post-BD in litres, median (p25-p75)

1.22 (0.97–2.02)

FEV1 post-BD as percentage, median (p25-p75)

62 (51–73)

FEV1/FVC, median (p25-p75)

0.56 (0.50–0.61)

Prediction scales

CAT, mean ± SD

17.4 ± 11.1

BODEx, mean ± SD

2.5 ± 1.73

  1. FVC: forced vital capacity; FEV1: forced expiratory volume in the first second; BD: bronchodilator; BODEx: BODE index; CAT: COPD Assessment Test. Values as mean ± standard deviation or median (p25-p75) or n (%)